Company Description
StemCells hopes a small focus will mean big business. The company discovers cell-based therapies to treat diseases of the central nervous system...
Key StemCells Financials
| Company Type | Public - NASDAQ (GM): STEM Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $0.1 |
| 2006 Employees | 46 |
More StemCells Financials (10 pages)
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about StemCells's competition across multiple industries
Top StemCells Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
StemCells Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | John J. Schwartz | Network | E-mail |
| President, CEO, and Director; President, StemCells California | Martin M. McGlynn | Network | E-mail |
| COO | Ann Tsukamoto | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Current StemCells News
- ASSAY FOR CELL CULTURE MEDIA AND MEDIA SUPPLEMENTS [PCT Biblio Info] (22 Jul 2008 14:03:00 EDT)
- BioWorld Today June 26, 2008 [BioWorld Today] (26 Jun 2008 00:01:00 EDT)
- StemCells Files Universal Shelf for up to $100 Mln in Securities [Midnight Trader] (25 Jun 2008 07:31:00 EDT)








